The Top 20 Companies In The Advanced Wound Care Market 2013-2023
Report Details
Advanced Wound Care - assess products, developments, and revenue prospects
How are companies in the advanced wound care market performing? Visiongain's updated report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions.
Our study lets you assess leading companies in the advanced wound care market, showing their prospects to 2023. There you see financial results, interviews, trends, opportunities, and revenue predictions. You will also find information on both established and rising companies.
Forecasts and other data to help you stay ahead
In our new study you find analytical profiles of 20 top companies - and analyses of the overall industry and leading segments - with historical data, revenue forecasts, growth rates, and market shares. Discover qualitative analysis too. You also gain 97 figures, 62 tables and interviews with two leading companies in the advanced wound care market.
Our work lets you assess the most lucrative parts of the world industry for advanced wound care products. See now how you can benefit your research, analyses, and decisions there, also saving time.
The following sections highlight what you find in our new investigation.
Assessments of top companies - activities, results, competition, and potential sales
Our report analyses the top 20 manufacturers of advanced wound care products. In general a company profile gives you the following information:
Prospects for the world advanced wound care market and its submarkets
First, our study gives you discussions, commercial outlooks and revenue forecasts for three advanced wound care submarkets to 2023:
North America - outlooks for leading companies in the advanced wound care market
Next, our report analyses 9 North American advanced wound care specialists, including these:
Europe - prospects for leading companies in the advanced wound care market
You also discover outlooks for 11 European advanced wound care specialists, including these:
Issues affecting the manufacturing and selling of advanced wound care products
In addition, our report discusses issues and events affecting that industry and market from 2013, including these:
Ways The Top 20 Companies in the Advanced Wound Care Market 2013-2023 helps you
In summary, then, our new research and analysis give you the following knowledge:
That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.
With our new survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.
Prospects for companies in the advanced wound care market - gain by ordering now
Our new analysis shows you data, trends, opportunities, and outlooks for producers and sellers of advanced wound care products. Avoid missing out - please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Advanced Wound Care - assess products, developments, and revenue prospects
How are companies in the advanced wound care market performing? Visiongain's updated report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions.
Our study lets you assess leading companies in the advanced wound care market, showing their prospects to 2023. There you see financial results, interviews, trends, opportunities, and revenue predictions. You will also find information on both established and rising companies.
Forecasts and other data to help you stay ahead
In our new study you find analytical profiles of 20 top companies - and analyses of the overall industry and leading segments - with historical data, revenue forecasts, growth rates, and market shares. Discover qualitative analysis too. You also gain 97 figures, 62 tables and interviews with two leading companies in the advanced wound care market.
Our work lets you assess the most lucrative parts of the world industry for advanced wound care products. See now how you can benefit your research, analyses, and decisions there, also saving time.
The following sections highlight what you find in our new investigation.
Assessments of top companies - activities, results, competition, and potential sales
Our report analyses the top 20 manufacturers of advanced wound care products. In general a company profile gives you the following information:
- Overview of the company, including its history in the advanced wound care market
- Discussion of a company's activities, outlook, and recent financial results
- Assessment of its developments - mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures
- Qualitative analysis of the company, identifying strengths over its competitors, as well as potential threats to sales growth
Prospects for the world advanced wound care market and its submarkets
First, our study gives you discussions, commercial outlooks and revenue forecasts for three advanced wound care submarkets to 2023:
- Moist Wound Care
- Wound Care Devices
- Wound Care Biologics
North America - outlooks for leading companies in the advanced wound care market
Next, our report analyses 9 North American advanced wound care specialists, including these:
- 3M
- ConvaTec
- Derma Sciences
- Hollister Incorporated
- Human Biosciences.
Europe - prospects for leading companies in the advanced wound care market
You also discover outlooks for 11 European advanced wound care specialists, including these:
- Smith & Nephew
- B.Braun Melsungen
- Coloplast
- Genzyme
- Molnlycke Health Care
Issues affecting the manufacturing and selling of advanced wound care products
In addition, our report discusses issues and events affecting that industry and market from 2013, including these:
- Traditional wound care - loosing market share with the growth of AWC
- AWC Market - witnessing a rise in M&A Activity
- Wound care biologics - taking centre stage with new bioactive products
- AWC Market driven by an aging population
- Expansion internationally - targeting emerging national markets
- Stem cells and Gene therapy - offer opportunities for growth
- High rivalry among competitors
Ways The Top 20 Companies in the Advanced Wound Care Market 2013-2023 helps you
In summary, then, our new research and analysis give you the following knowledge:
- Revenues to 2023 for the world advanced wound care market and its submarkets - discover that industry's prospects, finding promising places for investments and revenues
- Profiles of 20 leading companies - assess product ranges, strategies, financial results and commercial outlook to 2023.
- Competition and opportunities - see what affects the advanced wound care market, learning what shapes its future, esp. prospects for sustaining and developing business
- Analysis of what stimulates and restrains the advanced wound care industry - discover challenges and strengths, helping you compete and gain advantages
- Issues affecting established competitors and firms entering the advanced wound care sector - explore needs, practices, and outlooks for future success.
That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.
With our new survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.
Prospects for companies in the advanced wound care market - gain by ordering now
Our new analysis shows you data, trends, opportunities, and outlooks for producers and sellers of advanced wound care products. Avoid missing out - please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. EXECUTIVE SUMMARY
1.1 Overview
1.2 Leading AWC Manufacturers: Overview of Findings
1.3 Chapter Outline
1.4 Research and Analysis Method
1.5 Glossary of Terms Relating to Advanced Wound Care
2. INTRODUCTION
2.1 What is a Wound?
2.2 Wound Classification
2.2.1 Acute Wounds
2.2.2 Chronic Wounds
2.2.2.1 The Increasing Prevalence of Chronic Wounds
2.2.3 Burns
2.3 The Skin
2.4 The Phases of Wound Healing
2.4.1 The Inflammatory Phase
2.4.2 The Proliferation Phase
2.4.3 The Fibroblastic Phase
2.4.4 The Maturation Phase
2.5 Wound Care
2.5.1 Role of Wound Dressing
2.6 The History of Wound Care
2.7 Wound Care Categories
2.7.1 Traditional Wound Care
2.7.1.1 Gauze Dressings
2.7.1.2 Absorptive Dressings
2.7.1.3 Composite Dressings
2.7.1.4 Compression Therapy
2.7.1.5 Contact Layers
2.7.2 Advanced Wound Care (AWC)
2.7.2.1 Moist Wound Care (MWC)
2.7.2.1.1 Hydrocolloid Dressings
2.7.2.1.2 Foam Dressings
2.7.2.1.3 Alginate Dressings
2.7.2.1.4 Hydrogel Dressings
2.7.2.2 Wound Care Devices
2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.7.2.2.2 Ultrasound for Wound Therapy
2.7.2.3 Wound Care Biologics
2.7.2.3.1 Skin Replacement Therapies
2.7.2.3.2 Collagen Based Therapies
2.7.2.3.3 Cell Based Therapies
2.8 Regulation of Medical Devices
2.8.1 The US Regulation System
2.8.2 The European Approval and Regulation Process
3. THE GLOBAL ADVANCED WOUND CARE MARKET, 2013-2023
3.1 Global Wound Care Market, 2012
3.2 Global Wound Care Market Trends, 2012
3.3 Advanced Wound Care Market, 2012
3.4 Global Advanced Wound Care Market Forecast, 2012-2023
3.5 Advanced Wound Care Market: Drivers and Restrains, 2013-2023
3.6 Leading Advanced Wound Care Manufacturers, 2012
4. THE MOIST WOUND CARE MARKET, 2013-2023
4.1 The Moist Wound Care Market, 2012
4.2 The Moist Wound Care Market Forecast, 2012-2023
4.3 The Moist Wound Care Market Segments, 2012
4.3.1 The Hydrocolloid Dressings Market
4.3.2 The Foam Dressings Market
4.3.3 The Alginate Dressings Market
4.3.4 The Hydrogel Dressings Market
4.3.5 Other MWC Dressings Market
4.4 SWOT Analysis of the Moist Wound Care Market, 2013-2023
4.4.1 Strengths
4.4.1.1 Established Segment of the Market
4.4.1.2 Wide Variety of Products
4.4.1.3 More Effective than Traditional Wound Care
4.4.2 Weaknesses
4.4.2.1 Less Effective than Some Devices and Biologics
4.4.2.2 Weak R&D Pipeline
4.4.3 Opportunities
4.4.3.1 Increasing Prevalence of Chronic Wounds
4.4.3.2 Cheap Alternative to Devices and Biologics
4.4.4 Threats
4.4.4.1 Emerging Technologies May be More Effective
4.4.4.2 Lack of R&D Spending will Stifle Innovation
5. THE WOUND CARE DEVICES MARKET, 2013-2023
5.1 The Wound Care Devices Market, 2012
5.2 The Wound Care Devices Forecast, 2012-2023
5.3 The NPWT Segment Dominates Wound Care Devices Market
5.3.1 The NPWT Market Forecast, 2012-2023
5.4 Ultrasound Wound Therapy Market offers Potential for Growth
5.4.1 Ultrasound Wound Therapy Market Forecast, 2012-2023
5.5 SWOT Analysis of the Wound Care Devices Market, 2013-2023
5.5.1 Strengths
5.5.1.1 More Effective than Other Forms of Wound Care
5.5.1.2 Constant Innovation in the Market
5.5.2 Weaknesses
5.5.2.1 Dominated by Few Large Companies
5.5.2.2 NPWT Dominates the Market
5.5.3 Opportunities
5.5.3.1 Low Cost NPWT Systems will Drive Growth
5.5.3.2 Increasing Prevalence of Chronic Wounds
5.5.4 Threats
5.5.4.1 Controversy Regarding Safety of NPWT
6. THE WOUND CARE BIOLOGICS MARKET, 2013-2023
6.1 The Wound Care Biologics Market, 2012
6.2 The Wound Care Biologics Market Forecast, 2012-2023
6.3 The Skin Replacement Market: High Potential for Growth
6.3.1 The Skin Replacement Market Forecast, 2012-2023
6.4 Collagen Based Therapy Market
6.4.1 Collagen Based Therapy Market Forecast, 2012-2023
6.5 Cell Therapy Market: Fastest Growing Segment
6.5.1 Cell Therapy Market Forecast, 2012-2023
6.6 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
6.6.1 Strengths
6.6.1.1 More Effective than Other Forms of Wound Care
6.6.1.2 New Technology with Constant Innovation
6.6.1.3 Strong R&D Pipeline
6.6.2 Weaknesses
6.6.2.1 Small Start-up Companies Dominate the Market
6.6.2.2 Expensive Technology
6.6.2.3 High Barriers to Entry
6.6.3 Opportunities
6.6.3.1 Strong Innovation will Drive Growth
6.6.3.2 Stem Cells Offer Multiple Opportunities
6.6.3.3 Increasing Prevalence of Chronic Wounds
6.6.4 Threats
6.6.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.6.4.2 High Barriers to Entry will Deter Competitors
6.6.4.3 Competition from MWC and Devices
7. THE TOP COMPANIES IN THE NORTH AMERICAN ADVANCED WOUND CARE MARKET, 2013-2023
7.1 3M
7.1.1 Sales and Performance Analysis, 2012
7.1.2 Regional Sales Analysis, 2012
7.1.3 R&D Performance Analysis, 2012
7.1.4 AWC Product Portfolio, 2013
7.2 ConvaTec
7.2.1 Sales and Performance Analysis, 2012
7.2.2 Wound Therapeutics Sales Analysis, 2012
7.2.3 R&D Performance Analysis, 2012
7.2.4 AWC Product Portfolio, 2013
7.2.5 Recent M&A Activity
7.3 Covidien
7.3.1 Sales and Performance Analysis, 2012
7.3.2 Regional Sales Analysis, 2012
7.3.3 R&D Performance Analysis, 2012
7.3.4 AWC Product Portfolio, 2013
7.3.5 Recent M&A Activities
7.4 Derma Sciences
7.4.1 Sales and Performance Analysis, 2012
7.4.2 Advanced Wound Care Sales Analysis, 2012
7.4.3 R&D Performance Analysis, 2012
7.4.4 AWC Product Portfolio, 2013
7.4.5 Recent M&A Activity
7.4.5.1 Derma Sciences Acquired MedEfficiency Inc.,
7.5 Hollister Incorporated
7.5.1 AWC Product Portfolio, 2013
7.6 Human Biosciences Inc.,
7.6.1 AWC Product Portfolio, 2013
7.7 Kinetic Concepts Inc (KCI)
7.7.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn
7.7.2 KCI Continues to Dominate NPWT Market
7.7.3 AWC Product Portfolio, 2013
7.7.4 Recent M&A and Other Key Activities
7.7.4.1 Acquisition of MoMelan Technologies Inc in 2012
7.7.4.2 KCI Expands its Operations to Brazil
7.8 Medline Industries, Inc.
7.8.1 AWC Product Portfolio, 2013
7.9 Organogenesis
7.9.1 Apligraf, A Promising Wound Healing Product
7.9.2 FDA Approves GINTUIT
8. THE TOP COMPANIES IN THE EUROPEAN ADVANCED WOUND CARE MARKET, 2013-2023
8.1 Avita Medical
8.1.1 Sales and Performance Analysis, 2012
8.1.2 Product Portfolio, 2013
8.2 B.Braun Melsungen AG
8.2.1 Sales and Performance Analysis, 2012
8.2.2 AWC Product Portfolio, 2013
8.3 BSN Medical
8.3.1 AWC Product Portfolio, 2013
8.4 Coloplast
8.4.1 Coloplast Sales and Performance Analysis, 2012
8.4.2 Regional Sales Analysis, 2012
8.4.3 R&D Performance Analysis, 2012
8.4.4 Wound and Skin Care Sales Analysis, 2011/2012
8.4.5 AWC Product Portfolio, 2013
8.5 Genzyme (A Sanofi Company)
8.5.1 Epicel
8.6 HARTMANN GROUP
8.6.1 Sales and Performance Analysis, 2012
8.6.2 Regional Sales Analysis, 2012
8.6.3 AWC Product Portfolio, 2013
8.7 Laboratoires Urgo
8.7.1 Urgo Medical
8.7.2 AWC Product Portfolio, 2013
8.7.3 Recent M&A and Key Activities
8.7.3.1 Hollister Inc Continues Business Relation with Laboratories Urgo
8.8 Molnlycke Health Care
8.8.1 Sales and Performance Analysis, 2012
8.8.2 AWC Product Portfolio, 2013
8.8.3 Recent M&A Activity
8.8.3.1 Molnlycke Acquires WoundEL from Gerromed GmbH
8.8.3.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical
8.9 Shire
8.9.1 Sales and Performance Analysis, 2012
8.9.2 Shire Regenerative Medicine
8.9.3 DERMAGRAFT Sales Analysis, 2012
8.10 Smith & Nephew (S&N)
8.10.2 Advanced Wound Management Sales Analysis, 2012
8.10.3 Regional Sales Analysis, 2012
8.10.4 R&D Performance Analysis, 2012
8.10.5 AWC Product Portfolio, 2013
8.10.6 Smith & Nephew Pipeline
8.10.7 Recent M&A and Other Key Activities
8.10.7.1 Smith & Nephew Acquires Healthpoint Biotherapeutics
8.10.7.2 Purchase of Aderma Dermal Pads
8.10.7.3 Smith & Nephew Acquires Kalypto Medical
8.10.7.4 Regulatory Approvals in Advanced Wound Management, 2012
8.11 Systagenix Wound Management
8.11.1 AWC Product Portfolio, 2013
8.11.2 Recent M&A and Other Key Activities
8.11.2.1 Systagenix Forms Strategic Partnership with Sorbion
8.11.2.2 Systagenix Extends Sponsorship Agreement with Team Sky
8.11.2.3 Systagenix Acquires O2 Insights Inc
9. QUALITATIVE ANALYSIS OF THE ADVANCED WOUND CARE MARKET, 2013-2023
9.1 Porter's Five Force Analysis
9.1.1 Rivalry Among Competitors
9.1.2 Threat of New Entrants
9.1.3 Power of Suppliers
9.1.4 Power of Buyers
9.1.5 Threat of Substitutes
10. EXPERT OPINION
10.1 Interview with Derma Sciences
10.1.1 Perspective of Advanced Wound Care Market
10.1.2 Unmet Needs of the Industry
10.1.3 Do FDA Regulations Stifle Innovation?
10.1.4 Role of Moist Wound Care in the Future
10.1.5 Market for MEDIHONEY in Moist Wound Care
10.1.6 Key Products Driving Company Growth
10.1.7 Efficacy of Honey in Comparison to Silver
10.2 Interview with Shire Regenerative Medicine
10.2.1 Perspective of Wound Care Biologics Market
10.2.2 Cost and Reimbursement Issues
10.2.3 Outlook for DERMAGRAFT
11. CONCLUSIONS
11.1 The Advanced Wound Care Market, 2012-2023
11.2 KCI Dominated the Advanced Wound Care Market in 2012
11.3 Leading Companies are Focused on Moist Wound Care Market
11.4 Smaller Start Up Companies Dominate the Wound Care Biologics Market
1.1 Overview
1.2 Leading AWC Manufacturers: Overview of Findings
1.3 Chapter Outline
1.4 Research and Analysis Method
1.5 Glossary of Terms Relating to Advanced Wound Care
2. INTRODUCTION
2.1 What is a Wound?
2.2 Wound Classification
2.2.1 Acute Wounds
2.2.2 Chronic Wounds
2.2.2.1 The Increasing Prevalence of Chronic Wounds
2.2.3 Burns
2.3 The Skin
2.4 The Phases of Wound Healing
2.4.1 The Inflammatory Phase
2.4.2 The Proliferation Phase
2.4.3 The Fibroblastic Phase
2.4.4 The Maturation Phase
2.5 Wound Care
2.5.1 Role of Wound Dressing
2.6 The History of Wound Care
2.7 Wound Care Categories
2.7.1 Traditional Wound Care
2.7.1.1 Gauze Dressings
2.7.1.2 Absorptive Dressings
2.7.1.3 Composite Dressings
2.7.1.4 Compression Therapy
2.7.1.5 Contact Layers
2.7.2 Advanced Wound Care (AWC)
2.7.2.1 Moist Wound Care (MWC)
2.7.2.1.1 Hydrocolloid Dressings
2.7.2.1.2 Foam Dressings
2.7.2.1.3 Alginate Dressings
2.7.2.1.4 Hydrogel Dressings
2.7.2.2 Wound Care Devices
2.7.2.2.1 Negative Pressure Wound Therapy (NPWT)
2.7.2.2.2 Ultrasound for Wound Therapy
2.7.2.3 Wound Care Biologics
2.7.2.3.1 Skin Replacement Therapies
2.7.2.3.2 Collagen Based Therapies
2.7.2.3.3 Cell Based Therapies
2.8 Regulation of Medical Devices
2.8.1 The US Regulation System
2.8.2 The European Approval and Regulation Process
3. THE GLOBAL ADVANCED WOUND CARE MARKET, 2013-2023
3.1 Global Wound Care Market, 2012
3.2 Global Wound Care Market Trends, 2012
3.3 Advanced Wound Care Market, 2012
3.4 Global Advanced Wound Care Market Forecast, 2012-2023
3.5 Advanced Wound Care Market: Drivers and Restrains, 2013-2023
3.6 Leading Advanced Wound Care Manufacturers, 2012
4. THE MOIST WOUND CARE MARKET, 2013-2023
4.1 The Moist Wound Care Market, 2012
4.2 The Moist Wound Care Market Forecast, 2012-2023
4.3 The Moist Wound Care Market Segments, 2012
4.3.1 The Hydrocolloid Dressings Market
4.3.2 The Foam Dressings Market
4.3.3 The Alginate Dressings Market
4.3.4 The Hydrogel Dressings Market
4.3.5 Other MWC Dressings Market
4.4 SWOT Analysis of the Moist Wound Care Market, 2013-2023
4.4.1 Strengths
4.4.1.1 Established Segment of the Market
4.4.1.2 Wide Variety of Products
4.4.1.3 More Effective than Traditional Wound Care
4.4.2 Weaknesses
4.4.2.1 Less Effective than Some Devices and Biologics
4.4.2.2 Weak R&D Pipeline
4.4.3 Opportunities
4.4.3.1 Increasing Prevalence of Chronic Wounds
4.4.3.2 Cheap Alternative to Devices and Biologics
4.4.4 Threats
4.4.4.1 Emerging Technologies May be More Effective
4.4.4.2 Lack of R&D Spending will Stifle Innovation
5. THE WOUND CARE DEVICES MARKET, 2013-2023
5.1 The Wound Care Devices Market, 2012
5.2 The Wound Care Devices Forecast, 2012-2023
5.3 The NPWT Segment Dominates Wound Care Devices Market
5.3.1 The NPWT Market Forecast, 2012-2023
5.4 Ultrasound Wound Therapy Market offers Potential for Growth
5.4.1 Ultrasound Wound Therapy Market Forecast, 2012-2023
5.5 SWOT Analysis of the Wound Care Devices Market, 2013-2023
5.5.1 Strengths
5.5.1.1 More Effective than Other Forms of Wound Care
5.5.1.2 Constant Innovation in the Market
5.5.2 Weaknesses
5.5.2.1 Dominated by Few Large Companies
5.5.2.2 NPWT Dominates the Market
5.5.3 Opportunities
5.5.3.1 Low Cost NPWT Systems will Drive Growth
5.5.3.2 Increasing Prevalence of Chronic Wounds
5.5.4 Threats
5.5.4.1 Controversy Regarding Safety of NPWT
6. THE WOUND CARE BIOLOGICS MARKET, 2013-2023
6.1 The Wound Care Biologics Market, 2012
6.2 The Wound Care Biologics Market Forecast, 2012-2023
6.3 The Skin Replacement Market: High Potential for Growth
6.3.1 The Skin Replacement Market Forecast, 2012-2023
6.4 Collagen Based Therapy Market
6.4.1 Collagen Based Therapy Market Forecast, 2012-2023
6.5 Cell Therapy Market: Fastest Growing Segment
6.5.1 Cell Therapy Market Forecast, 2012-2023
6.6 SWOT Analysis of the Wound Care Biologics Market, 2012-2023
6.6.1 Strengths
6.6.1.1 More Effective than Other Forms of Wound Care
6.6.1.2 New Technology with Constant Innovation
6.6.1.3 Strong R&D Pipeline
6.6.2 Weaknesses
6.6.2.1 Small Start-up Companies Dominate the Market
6.6.2.2 Expensive Technology
6.6.2.3 High Barriers to Entry
6.6.3 Opportunities
6.6.3.1 Strong Innovation will Drive Growth
6.6.3.2 Stem Cells Offer Multiple Opportunities
6.6.3.3 Increasing Prevalence of Chronic Wounds
6.6.4 Threats
6.6.4.1 Controversy Regarding the Effectiveness of Some Biologics
6.6.4.2 High Barriers to Entry will Deter Competitors
6.6.4.3 Competition from MWC and Devices
7. THE TOP COMPANIES IN THE NORTH AMERICAN ADVANCED WOUND CARE MARKET, 2013-2023
7.1 3M
7.1.1 Sales and Performance Analysis, 2012
7.1.2 Regional Sales Analysis, 2012
7.1.3 R&D Performance Analysis, 2012
7.1.4 AWC Product Portfolio, 2013
7.2 ConvaTec
7.2.1 Sales and Performance Analysis, 2012
7.2.2 Wound Therapeutics Sales Analysis, 2012
7.2.3 R&D Performance Analysis, 2012
7.2.4 AWC Product Portfolio, 2013
7.2.5 Recent M&A Activity
7.3 Covidien
7.3.1 Sales and Performance Analysis, 2012
7.3.2 Regional Sales Analysis, 2012
7.3.3 R&D Performance Analysis, 2012
7.3.4 AWC Product Portfolio, 2013
7.3.5 Recent M&A Activities
7.4 Derma Sciences
7.4.1 Sales and Performance Analysis, 2012
7.4.2 Advanced Wound Care Sales Analysis, 2012
7.4.3 R&D Performance Analysis, 2012
7.4.4 AWC Product Portfolio, 2013
7.4.5 Recent M&A Activity
7.4.5.1 Derma Sciences Acquired MedEfficiency Inc.,
7.5 Hollister Incorporated
7.5.1 AWC Product Portfolio, 2013
7.6 Human Biosciences Inc.,
7.6.1 AWC Product Portfolio, 2013
7.7 Kinetic Concepts Inc (KCI)
7.7.1 Apax Partners' Led Consortium Acquires KCI for $6.3bn
7.7.2 KCI Continues to Dominate NPWT Market
7.7.3 AWC Product Portfolio, 2013
7.7.4 Recent M&A and Other Key Activities
7.7.4.1 Acquisition of MoMelan Technologies Inc in 2012
7.7.4.2 KCI Expands its Operations to Brazil
7.8 Medline Industries, Inc.
7.8.1 AWC Product Portfolio, 2013
7.9 Organogenesis
7.9.1 Apligraf, A Promising Wound Healing Product
7.9.2 FDA Approves GINTUIT
8. THE TOP COMPANIES IN THE EUROPEAN ADVANCED WOUND CARE MARKET, 2013-2023
8.1 Avita Medical
8.1.1 Sales and Performance Analysis, 2012
8.1.2 Product Portfolio, 2013
8.2 B.Braun Melsungen AG
8.2.1 Sales and Performance Analysis, 2012
8.2.2 AWC Product Portfolio, 2013
8.3 BSN Medical
8.3.1 AWC Product Portfolio, 2013
8.4 Coloplast
8.4.1 Coloplast Sales and Performance Analysis, 2012
8.4.2 Regional Sales Analysis, 2012
8.4.3 R&D Performance Analysis, 2012
8.4.4 Wound and Skin Care Sales Analysis, 2011/2012
8.4.5 AWC Product Portfolio, 2013
8.5 Genzyme (A Sanofi Company)
8.5.1 Epicel
8.6 HARTMANN GROUP
8.6.1 Sales and Performance Analysis, 2012
8.6.2 Regional Sales Analysis, 2012
8.6.3 AWC Product Portfolio, 2013
8.7 Laboratoires Urgo
8.7.1 Urgo Medical
8.7.2 AWC Product Portfolio, 2013
8.7.3 Recent M&A and Key Activities
8.7.3.1 Hollister Inc Continues Business Relation with Laboratories Urgo
8.8 Molnlycke Health Care
8.8.1 Sales and Performance Analysis, 2012
8.8.2 AWC Product Portfolio, 2013
8.8.3 Recent M&A Activity
8.8.3.1 Molnlycke Acquires WoundEL from Gerromed GmbH
8.8.3.2 Molnlycke Acquires Burn and Wound Care Business of Brennen Medical
8.9 Shire
8.9.1 Sales and Performance Analysis, 2012
8.9.2 Shire Regenerative Medicine
8.9.3 DERMAGRAFT Sales Analysis, 2012
8.10 Smith & Nephew (S&N)
8.10.2 Advanced Wound Management Sales Analysis, 2012
8.10.3 Regional Sales Analysis, 2012
8.10.4 R&D Performance Analysis, 2012
8.10.5 AWC Product Portfolio, 2013
8.10.6 Smith & Nephew Pipeline
8.10.7 Recent M&A and Other Key Activities
8.10.7.1 Smith & Nephew Acquires Healthpoint Biotherapeutics
8.10.7.2 Purchase of Aderma Dermal Pads
8.10.7.3 Smith & Nephew Acquires Kalypto Medical
8.10.7.4 Regulatory Approvals in Advanced Wound Management, 2012
8.11 Systagenix Wound Management
8.11.1 AWC Product Portfolio, 2013
8.11.2 Recent M&A and Other Key Activities
8.11.2.1 Systagenix Forms Strategic Partnership with Sorbion
8.11.2.2 Systagenix Extends Sponsorship Agreement with Team Sky
8.11.2.3 Systagenix Acquires O2 Insights Inc
9. QUALITATIVE ANALYSIS OF THE ADVANCED WOUND CARE MARKET, 2013-2023
9.1 Porter's Five Force Analysis
9.1.1 Rivalry Among Competitors
9.1.2 Threat of New Entrants
9.1.3 Power of Suppliers
9.1.4 Power of Buyers
9.1.5 Threat of Substitutes
10. EXPERT OPINION
10.1 Interview with Derma Sciences
10.1.1 Perspective of Advanced Wound Care Market
10.1.2 Unmet Needs of the Industry
10.1.3 Do FDA Regulations Stifle Innovation?
10.1.4 Role of Moist Wound Care in the Future
10.1.5 Market for MEDIHONEY in Moist Wound Care
10.1.6 Key Products Driving Company Growth
10.1.7 Efficacy of Honey in Comparison to Silver
10.2 Interview with Shire Regenerative Medicine
10.2.1 Perspective of Wound Care Biologics Market
10.2.2 Cost and Reimbursement Issues
10.2.3 Outlook for DERMAGRAFT
11. CONCLUSIONS
11.1 The Advanced Wound Care Market, 2012-2023
11.2 KCI Dominated the Advanced Wound Care Market in 2012
11.3 Leading Companies are Focused on Moist Wound Care Market
11.4 Smaller Start Up Companies Dominate the Wound Care Biologics Market
LIST OF TABLES
Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Advantages and Disadvantages of Moist Wound Care
Table 2.5 The Benefits and Risks of Skin Grafting
Table 3.1 Global Wound Care Market: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 3.2 The Advanced Wound Care Market: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 3.3 The Advanced Wound Care Market Forecast ($bn, AGR%, CAGR%) by Segment, 2012-2017
Table 3.4 The Advanced Wound Care Market Forecast ($bn, AGR%, CAGR%) by Segment, 2017-2023
Table 3.5 The Advanced Wound Care Market by Leading Companies: Revenue ($bn) and Market Shares (%), 2012
Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2012
Table 4.2 The Moist Wound Care Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 4.3 The Moist Wound Care Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 4.4 SWOT Analysis of the Moist Wound Care Market, 2013-2023
Table 5.1 The Wound Care Devices Market: Revenue ($bn) and Market Shares (%) by Segment, 2012
Table 5.2 The Wound Care Devices Market Forecast ($bn, AGR%, CAGR %), 2012-2017
Table 5.3 The Wound Care Devices Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.4 The NPWT Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 5.5 The NPWT Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.6 The Ultrasound Wound Therapy Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 5.7 The Ultrasound Wound Therapy Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.8 SWOT Analysis of the Wound Care Devices Market, 2013-2023
Table 6.1 The Wound Care Biologics Market: Revenue ($m) and Market Shares (%) by Segment, 2012
Table 6.2 The Wound Care Biologics Market Forecast ($m, AGR% CAGR%), 2012-2017
Table 6.3 The Wound Care Biologics Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.4 The Skin Replacement Market Forecast ($m, AGR% CAGR %), 2012-2017
Table 6.5 The Skin Replacement Market Forecast ($m, AGR%, CAGR %), 2017-2023
Table 6.6 The Collagen Based Therapy Market Forecast ($m, AGR%, CAGR%), 2012-2017
Table 6.7 The Collagen Based Therapy Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.8 The Cell Therapy Market Forecast ($m, AGR%, CAGR%), 2012-2017
Table 6.9 The Cell Therapy Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.10 SWOT Analysis of the Wound Care Biologics Market, 2013-2023
Table 7.1 3M: Net Sales ($bn) and Net Sales Shares (%) by Business Segment, 2012
Table 7.2 3M: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 7.3 3M: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Table 7.4 ConvaTec: Net Sales ($m) and Net Sales Share (%) by Franchise, 2012
Table 7.5 ConvaTec: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Net Sales (%), 2009-2012
Table 7.6 Covidien: Net Sales ($bn) and Net Sales Shares (%) by Segment, 2012
Table 7.7 Covidien: Medical Supplies Net Sales ($bn) and Net Sales Shares (%) by Segment, 2012
Table 7.8 Covidien: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 7.9 Covidien: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Table 7.10 Covidien: Advanced Wound Care Product Portfolio, 2013
Table 7.11 Derma Sciences: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 7.12 Derma Sciences: Historical Advanced Wound Care Revenue ($m) and % Growth, 2007-2012
Table 7.13 Derma Sciences: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2008-2012
Table 7.14 VAC Therapy at a Glance, 2013
Table 8.1 Avita Medical: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.2 Avita Medical: Total Revenue ($m) in 2011 and 2012
Table 8.3 B.Braun: Sales ($bn) and Sales Shares (%) by Business Segment, 2012
Table 8.4 Coloplast: Revenue ($m) and Revenue Shares (%) by Business, 2011/2012
Table 8.5 Coloplast: Revenue ($m) and Revenue Shares (%) by Region, 2011/2012
Table 8.6 Coloplast: R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2007-2012
Table 8.7 HARTMANN GROUP: Net Sales ($bn) and Net Sales Shares (%) by Business Segment, 2012
Table 8.8 HARTMANN GROUP: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 8.9 Molnlycke: Historical Net Sales ($bn) and Net Debt ($bn), 2008-2012
Table 8.10 Shire: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 8.11 Shire: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.12 Smith & Nephew: Revenue ($bn) and Revenue Shares (%) by Business Division, 2012
Table 8.13 Smith & Nephew: AWM Revenue ($bn) and Revenue Shares (%) by Franchise, 2012
Table 8.14 Smith & Nephew: AWM Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 8.15 Smith & Nephew: Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 11.1 Segments in the Advanced Wound Care Market: Sales ($bn) in 2012, 2017, 2019 and 2023
Table 2.1 The Rules of Nine: Percentage (%) of Total Body Classification System
Table 2.2 The Classification of Burns by Depth: Degree Classification System
Table 2.3 The Classification of Burns by Severity
Table 2.4 The Advantages and Disadvantages of Moist Wound Care
Table 2.5 The Benefits and Risks of Skin Grafting
Table 3.1 Global Wound Care Market: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 3.2 The Advanced Wound Care Market: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 3.3 The Advanced Wound Care Market Forecast ($bn, AGR%, CAGR%) by Segment, 2012-2017
Table 3.4 The Advanced Wound Care Market Forecast ($bn, AGR%, CAGR%) by Segment, 2017-2023
Table 3.5 The Advanced Wound Care Market by Leading Companies: Revenue ($bn) and Market Shares (%), 2012
Table 4.1 The Moist Wound Care Market: Revenue ($bn) and Market Shares (%) by Segment, 2012
Table 4.2 The Moist Wound Care Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 4.3 The Moist Wound Care Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 4.4 SWOT Analysis of the Moist Wound Care Market, 2013-2023
Table 5.1 The Wound Care Devices Market: Revenue ($bn) and Market Shares (%) by Segment, 2012
Table 5.2 The Wound Care Devices Market Forecast ($bn, AGR%, CAGR %), 2012-2017
Table 5.3 The Wound Care Devices Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.4 The NPWT Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 5.5 The NPWT Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.6 The Ultrasound Wound Therapy Market Forecast ($bn, AGR%, CAGR%), 2012-2017
Table 5.7 The Ultrasound Wound Therapy Market Forecast ($bn, AGR%, CAGR%), 2017-2023
Table 5.8 SWOT Analysis of the Wound Care Devices Market, 2013-2023
Table 6.1 The Wound Care Biologics Market: Revenue ($m) and Market Shares (%) by Segment, 2012
Table 6.2 The Wound Care Biologics Market Forecast ($m, AGR% CAGR%), 2012-2017
Table 6.3 The Wound Care Biologics Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.4 The Skin Replacement Market Forecast ($m, AGR% CAGR %), 2012-2017
Table 6.5 The Skin Replacement Market Forecast ($m, AGR%, CAGR %), 2017-2023
Table 6.6 The Collagen Based Therapy Market Forecast ($m, AGR%, CAGR%), 2012-2017
Table 6.7 The Collagen Based Therapy Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.8 The Cell Therapy Market Forecast ($m, AGR%, CAGR%), 2012-2017
Table 6.9 The Cell Therapy Market Forecast ($m, AGR%, CAGR%), 2017-2023
Table 6.10 SWOT Analysis of the Wound Care Biologics Market, 2013-2023
Table 7.1 3M: Net Sales ($bn) and Net Sales Shares (%) by Business Segment, 2012
Table 7.2 3M: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 7.3 3M: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Table 7.4 ConvaTec: Net Sales ($m) and Net Sales Share (%) by Franchise, 2012
Table 7.5 ConvaTec: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Net Sales (%), 2009-2012
Table 7.6 Covidien: Net Sales ($bn) and Net Sales Shares (%) by Segment, 2012
Table 7.7 Covidien: Medical Supplies Net Sales ($bn) and Net Sales Shares (%) by Segment, 2012
Table 7.8 Covidien: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 7.9 Covidien: Historical R&D Expenses ($bn) and R&D Expenses as Percentage of Net Sales (%), 2008-2012
Table 7.10 Covidien: Advanced Wound Care Product Portfolio, 2013
Table 7.11 Derma Sciences: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 7.12 Derma Sciences: Historical Advanced Wound Care Revenue ($m) and % Growth, 2007-2012
Table 7.13 Derma Sciences: Historical R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2008-2012
Table 7.14 VAC Therapy at a Glance, 2013
Table 8.1 Avita Medical: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.2 Avita Medical: Total Revenue ($m) in 2011 and 2012
Table 8.3 B.Braun: Sales ($bn) and Sales Shares (%) by Business Segment, 2012
Table 8.4 Coloplast: Revenue ($m) and Revenue Shares (%) by Business, 2011/2012
Table 8.5 Coloplast: Revenue ($m) and Revenue Shares (%) by Region, 2011/2012
Table 8.6 Coloplast: R&D Expenses ($m) and R&D Expenses as Percentage of Revenue (%), 2007-2012
Table 8.7 HARTMANN GROUP: Net Sales ($bn) and Net Sales Shares (%) by Business Segment, 2012
Table 8.8 HARTMANN GROUP: Net Sales ($bn) and Net Sales Shares (%) by Region, 2012
Table 8.9 Molnlycke: Historical Net Sales ($bn) and Net Debt ($bn), 2008-2012
Table 8.10 Shire: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 8.11 Shire: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.12 Smith & Nephew: Revenue ($bn) and Revenue Shares (%) by Business Division, 2012
Table 8.13 Smith & Nephew: AWM Revenue ($bn) and Revenue Shares (%) by Franchise, 2012
Table 8.14 Smith & Nephew: AWM Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 8.15 Smith & Nephew: Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 11.1 Segments in the Advanced Wound Care Market: Sales ($bn) in 2012, 2017, 2019 and 2023
R&D Performance Analysis, 2012
3M always has its name in the top when it comes to innovation. The R&D expenses increased 4.1% in 2012 compared to 2011 and increased 9.5% in 2011 compared to 2010. In 2012, the R&D expenses totalled to $1.6bn, accounting for 5.5% of net sales. Visiongain believes that a major share of the revenue generated in 2012 was from products introduced in the last 5 years. The company CEO in a recent press release mentioned that 3M firmly believes in innovating during a downturn than good times. R&D expenses measured as a percentage of sales, was 5.5% in 2012, compared to 5.3% in 2011 and 5.4% in 2010.
AWC Product Portfolio, 2013
3M manufactures its advanced wound care dressings under the brand name Tegaderm. 3M began the work on inventing Tegaderm film dressing back in 1978. Three years later, the first test product was launched in the US and in 1987 became the market leader in transparent film dressings.
Having more than 30 years of experience in the wound care market, 3M still continues to innovate and bring in more products into the wound care market. This section describes the product portfolio of 3M in 2013.
3M Tegaderm Hydrocolloid Dressing: Consists of thin polyurethane membrane coated with layer of acrylic adhesive. Permeable to oxygen and water vapour, but impermeable to bacteria and virus. It is indicated for use on minor burns, skin and pressure ulcers and acute wounds.
• 3M Tegaderm Foam Dressing: Made up of polyurethane foam pad and additional absorbent non woven layer. Bordered by transparent adhesive film
• 3M Tegaderm Alginate Dressing: Derived from pure Scottish seaweed. Soft in texture and absorbs more than its own weight. Indicated for chronic and acute wounds.
• 3M Tegaderm Alginate Ag Dressing: Highly absorbent, sterile dressing composed of calcium alginate. Indicated for chronic and acute wounds.
• 3M Tegaderm Hydrogel Dressing: Provides moist healing and promotes debridement. Indicated for minimally draining partial and full thickness dermal wounds.
• 3M Tegaderm Film Dressings: Transparent film dressing providing water resistant breathable barrier to external contaminants.
